March 13, 2020 / 9:08 PM / 15 days ago

BRIEF-Stemline Therapeutics Posts Quarterly Loss Per Share Of $0.38

March 13 (Reuters) - Stemline Therapeutics Inc:

* STEMLINE THERAPEUTICS REPORTS FOURTH QUARTER 2019 FINANCIAL RESULTS

* Q4 REVENUE $11.8 MILLION VERSUS REFINITIV IBES ESTIMATE OF $13.6 MILLION

* QTRLY LOSS PER SHARE $0.38 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below